Researchers affiliated with Kawasaki INnovation Gateway at SKYFRONT (KING SKYFRONT) and their collaborators report on antibody delivery technology that empowers immunotherapy against glioblastoma and suppresses side effects, and creating smart nanomachines to detect highly invasive cancer after surgery and prevent recurrence.
Read More at:
Copyright © PassionIT News.com
All right Reserved 2020